)
American Vanguard (AVD) investor relations material
American Vanguard Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
2025 was a challenging year for the agricultural sector, with net sales declining to $515 million, but operational, digital, and organizational initiatives improved safety, reduced costs, and positioned the company for long-term success.
Adjusted EBITDA for 2025 was $39.2 million, nearly flat compared to $39.1 million in 2024, reflecting cost controls and improved margins.
Rationalization of the Los Angeles facility and headquarters relocation are expected to save $4 million and $0.5 million annually, with both moves to be completed by end of Q2 2026.
Flexible refinancing was secured with two term loans, providing stability and no equity dilution, but at a higher average interest rate.
New product launches and a focus on customer needs are expected to drive higher-margin revenue and long-term growth.
Financial highlights
2025 sales were $515 million, down 6% year-over-year from $547 million, slightly below the $520–$535 million target.
Gross profit margin improved to 29% in 2025 from 22% in 2024, with OpEx as a percentage of sales decreasing to 27%.
Adjusted EBITDA for 2025 was $39.2 million, nearly flat compared to $39.1 million in 2024, but below the $40–$44 million target due to sluggish Q4 sales.
Gross profit rose to $147.6 million in 2025, up 23% year-over-year.
Specialty sales grew 10%, driven by a joint development agreement and growth in mosquito vector solutions.
Outlook and guidance
2026 adjusted EBITDA is projected at $44–$48 million on sales of $530–$550 million.
At least $100 million in additional annual revenue is expected globally over the medium term from new products, with most new product sales ramping up from 2028.
Long-term EBITDA margin target remains at 15%, with a planned CAGR of 4–6% in sales.
Free cash flow is expected to be positive in 2026, given EBITDA projections and CapEx in the $5–$10 million range.
Strategic focus on increasing volumes and new products is expected to drive sales and profitability.
- Q2 sales and margins fell, guidance was cut, and transformation and cost-saving efforts accelerated.AVD
Q2 20242 Feb 2026 - Q3 loss and sales drop driven by recall, but guidance and non-crop growth remain strong.AVD
Q3 202415 Jan 2026 - Transformation plan aims for 15% EBITDA margin and growth in biologicals by 2025.AVD
Gabelli Funds' 16th Annual Specialty Chemicals Symposium26 Dec 2025 - 2024 EBITDA met guidance as debt and inventory fell; 2025 targets higher revenue and margin.AVD
Q4 202424 Dec 2025 - Virtual meeting to elect directors, ratify auditor, and approve performance-based executive pay.AVD
Proxy Filing2 Dec 2025 - Adjusted EBITDA up 350%, gross margin 29%, and net loss narrowed on strong U.S. crop sales.AVD
Q3 202517 Nov 2025 - Q1 sales dropped 14% with a net loss, but cost cuts and lower debt support recovery.AVD
Q1 202514 Nov 2025 - Adjusted EBITDA nearly doubled and gross margin hit a five-quarter high as net loss narrowed.AVD
Q2 20257 Aug 2025
Next American Vanguard earnings date
Next American Vanguard earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)